Cargando…

Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth

Therapeutic strategies for ARID1A-mutant ovarian cancers are limited. Higher basal reactive oxygen species (ROS) and lower basal glutathione (GSH) empower the aggressive proliferation ability and strong metastatic property of OCCCs, indicated by the increased marker of epithelial-mesenchymal transit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Xuejia, Wang, Qi, Wu, Siqi, Wang, Chuanyu, Annaji, Manjusha, Huang, Chung-Hui, Shen, Jianzhong, Chen, Pengyu, Babu, R. Jayachandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216151/ https://www.ncbi.nlm.nih.gov/pubmed/37238613 http://dx.doi.org/10.3390/biom13050744

Ejemplares similares

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
por: Kang, Xuejia, et al.
Publicado: (2023)

pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines
por: Alrbyawi, Hamad, et al.
Publicado: (2022)

Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines
por: Alrbyawi, Hamad, et al.
Publicado: (2022)

Hispolon Cyclodextrin Complexes and Their Inclusion in Liposomes for Enhanced Delivery in Melanoma Cell Lines
por: Poudel, Ishwor, et al.
Publicado: (2022)

Inclusion Complex of Clomiphene Citrate with Hydroxypropyl-β-Cyclodextrin for Intravenous Injection: Formulation and Stability Studies
por: Annaji, Manjusha, et al.
Publicado: (2023)

Resveratrol‐loaded nanomedicines for cancer applications
por: Annaji, Manjusha, et al.
Publicado: (2021)

Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity
por: Pundkar, Chetan, et al.
Publicado: (2023)

Clinical outcomes of chemotherapy in cancer patients with different ethnicities
por: Pathak, Suhrud, et al.
Publicado: (2023)

DQ2, DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac Cases and Their First-Degree Relatives
por: Araya, Magdalena, et al.
Publicado: (2015)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ
por: Basturk, Ahmet, et al.
Publicado: (2017)

HLA-DQ2 and -DQ8 genotype frequency in Syrian celiac disease children: HLA-DQ relative risks evaluation
por: Murad, Hossam, et al.
Publicado: (2018)

ARID1B is a specific vulnerability in ARID1A-mutant cancers
por: Helming, Katherine C., et al.
Publicado: (2014)

Topical Delivery of Diacetyl Boldine in a Microemulsion Formulation for Chemoprotection against Melanoma
por: Al Saqr, Ahmed, et al.
Publicado: (2023)

THE PREVALENCE OF HLA DQ2 AND DQ8 IN PATIENTS WITH CELIAC DISEASE, IN FAMILY AND IN GENERAL POPULATION
por: CECILIO, Lucila Arantes, et al.
Publicado: (2015)

The likelihood ratio and frequency of DQ2/DQ8 haplotypes in Iranian patients with celiac disease
por: Khosravi, Asghar, et al.
Publicado: (2016)

Presence of DQ2.2 Associated with DQ2.5 Increases the Risk for Celiac Disease
por: Almeida, Lucas Malta, et al.
Publicado: (2016)

Prevalence of haplotype DQ2/DQ8 and celiac disease in children with type 1 diabetes
por: Zubkiewicz-Kucharska, Agnieszka, et al.
Publicado: (2022)

Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease
por: Aboulaghras, Sara, et al.
Publicado: (2023)

Relevance of HLA-DP/DQ and ICAM-1 SNPs among Ovarian Cancer Patients
por: Ghazy, Amany A., et al.
Publicado: (2016)

Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition
Publicado: (1990)

HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes
por: Bezstarosti, Suzanne, et al.
Publicado: (2022)

ATLAS DQ2 Deletion Service
por: OLEYNIK, D, et al.
Publicado: (2012)

ATLAS DQ2 Deletion Service
por: OLEYNIK, D, et al.
Publicado: (2012)

ATLAS DQ2 DELETION SERVICE
por: Oleynik, D, et al.
Publicado: (2012)

Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
por: Zhao, Lue Ping, et al.
Publicado: (2020)

Evaluation of HLA-DQ2/DQ8 genotype in patients with celiac disease hospitalised in 2012 at the Department of Paediatrics
por: Szałowska-Woźniak, Dorota A., et al.
Publicado: (2014)

Human Leukocyte Antigen DQ (HLA‐DQ) genotypes and haplotypes and their association with phenotype in patients with celiac disease in India
por: Ramakrishna, Balakrishnan S, et al.
Publicado: (2021)

Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires
por: Bergseng, Elin, et al.
Publicado: (2014)

Fequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil
por: Castro-Antunes, Margarida Maria, et al.
Publicado: (2011)

HLA-DQ2 and -DQ8 haplotypes frequency and diagnostic utility in celiac disease patients of Gaza strip, Palestine
por: Ayesh, Basim M., et al.
Publicado: (2017)

Frequency of celiac disease and distribution of HLA-DQ2/DQ8 haplotypes among siblings of children with celiac disease
por: Sahin, Yasin, et al.
Publicado: (2022)

Senolytics (DQ) Mitigates Radiation Ulcers by Removing Senescent Cells
por: Wang, Huilan, et al.
Publicado: (2020)

ATLAS DQ2 to Rucio renaming infrastructure
por: Serfon, C, et al.
Publicado: (2013)

ATLAS DQ2 to Rucio renaming infrastructure
por: Serfon, C, et al.
Publicado: (2013)

The frequency of HLA-DQ2/DQ8 haplotypes and celiac disease among the first-degree relatives of patients with celiac disease
por: Mansouri, Masoume, et al.
Publicado: (2021)

Assessing the Prevalence of HLA-DQ2 and HLA-DQ8 in Lipedema Patients and the Potential Benefits of a Gluten-Free Diet
por: Amato, Alexandre C, et al.
Publicado: (2023)

Peptide binding predictions for HLA DR, DP and DQ molecules
por: Wang, Peng, et al.
Publicado: (2010)

An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP
Publicado: (1991)

Human leukocyte antigen (HLA)-DQ2 and -DQ8 haplotypes in celiac, celiac with type 1 diabetic, and celiac suspected pediatric cases
por: Siddiqui, Komal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_im13s9age1keta2jmcuj4u97eo